AbbVie to Host Full-Year and Fourth-Quarter 2024 Earnings Conference Call
Rhea-AI Summary
AbbVie (NYSE: ABBV) has announced it will release its full-year and fourth-quarter 2024 financial results on Friday, January 31, 2025, before market opening. The company will host a live webcast earnings conference call at 8 a.m. Central time, which will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived version of the session will be made available later that day.
Positive
- None.
Negative
- None.
News Market Reaction – ABBV
In the trading session that priced this news, ABBV gained 0.99%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X (formerly Twitter), and YouTube.
View original content to download multimedia:https://www.prnewswire.com/news-releases/abbvie-to-host-full-year-and-fourth-quarter-2024-earnings-conference-call-302340337.html
SOURCE AbbVie
